RBM38: RNA Binding Motif Protein 38

A key regulator of mRNA splicing and stability in development and cancer

Gene Information Card

Symbol RBM38
Full Name RNA binding motif protein 38
Gene Type protein-coding
Chromosomal Location 20q13.31
NCBI Gene ID 55544 ncbi.nlm.nih.gov/gene/55544
Ensembl ID ENSG00000101204
UniProt ID Q9H0Z9
OMIM ID 612525
HGNC ID HGNC:29018
Aliases RNPC1, SEB4D, RNA-binding motif protein 38

Description

RBM38 (RNA binding motif protein 38) encodes an RNA-binding protein that belongs to the RRM (RNA recognition motif) family. It regulates post-transcriptional gene expression by binding to target mRNAs, influencing splicing, stability, and translation. RBM38 is involved in cell cycle control, differentiation, and apoptosis, and is frequently dysregulated in various cancers, acting as a tumor suppressor in some contexts.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer RBM38 downregulation leads to increased expression of oncogenic targets (e.g., MYC, CCND1) and promotes proliferation ClinVar, COSMIC
Colorectal cancer Loss of RBM38 expression correlates with poor prognosis and enhanced tumor growth NCBI Gene, COSMIC
Hepatocellular carcinoma RBM38 suppresses tumorigenesis by modulating mRNA stability of cell cycle regulators UniProt, OMIM
Acute myeloid leukemia RBM38 mutations or altered splicing contribute to leukemogenesis COSMIC, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Breast 2.3 Low
Colon 1.8 Low
Liver 3.1 Low
Lung 1.5 Low
Ovary 2.0 Low
Testis 5.4 Medium
Spleen 4.2 Medium
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 1.2 Low expression; associated with poor prognosis
HCT116 (colorectal cancer) 0.8 Very low; loss of tumor suppressor function
HepG2 (hepatocellular carcinoma) 2.5 Moderate; reduced compared to normal liver
K562 (leukemia) 3.0 Moderate; mutations reported
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) missense Rare Loss of start codon; likely loss of function
c.214C>T (p.Arg72Trp) missense 0.01% Alters RNA-binding affinity; potential loss of function
c.487_489del (p.Lys163del) deletion 0.005% In-frame deletion in RRM domain; disrupts target binding
Mutation functional classification

Loss of Function (LOF)

Most reported mutations (e.g., p.Met1?, p.Arg72Trp) reduce or abolish RNA-binding activity, leading to loss of tumor suppression.

Gain of Function (GOF)

No gain-of-function mutations documented in COSMIC or ClinVar.

Dominant Negative (DN)

Not reported; no evidence of dominant-negative effects.

Pathways

Post-transcriptional regulation of gene expression
mRNA surveillance pathway
p53 signaling pathway (via regulation of CDKN1A/p21)

Protein Summary

RBM38 is a 238-amino acid RNA-binding protein containing a single N-terminal RRM domain. It binds to AU-rich elements (AREs) in the 3' UTR of target mRNAs, modulating their stability and translation. RBM38 promotes cell cycle arrest and apoptosis by stabilizing CDKN1A (p21) mRNA and destabilizing oncogenic transcripts like MYC and CCND1. Its expression is frequently lost in cancers, correlating with aggressive disease.

Related Products

Product name Cat.No. Species Gene ID
RBM38 Knockout HEK293 Cell Line EDJ-KQ15008 Human 55544 Details Get a Quote
RBM38 Knockout A-549 Cell Line EDJ-KQ45537 Human 55544 Details Get a Quote
RBM38 Knockout HCT 116 Cell Line EDJ-KQ45538 Human 55544 Details Get a Quote
RBM38 Knockout HeLa Cell Line EDJ-KQ45539 Human 55544 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: